De santis, Maria
 Distribuzione geografica
Continente #
NA - Nord America 4.582
AS - Asia 3.361
EU - Europa 1.246
AF - Africa 724
SA - Sud America 695
OC - Oceania 7
Totale 10.615
Nazione #
US - Stati Uniti d'America 4.495
SG - Singapore 2.060
SC - Seychelles 611
BR - Brasile 572
CN - Cina 557
VN - Vietnam 322
IT - Italia 239
FI - Finlandia 225
IE - Irlanda 156
DE - Germania 131
FR - Francia 98
HK - Hong Kong 90
IN - India 88
GB - Regno Unito 80
NL - Olanda 56
AR - Argentina 51
NG - Nigeria 45
MX - Messico 38
RU - Federazione Russa 38
SE - Svezia 37
CA - Canada 34
BD - Bangladesh 32
PL - Polonia 32
ZA - Sudafrica 28
IQ - Iraq 25
CZ - Repubblica Ceca 21
EC - Ecuador 21
TR - Turchia 21
MK - Macedonia 20
ID - Indonesia 18
CO - Colombia 17
ES - Italia 17
JP - Giappone 16
BE - Belgio 15
PK - Pakistan 15
PH - Filippine 14
SA - Arabia Saudita 12
UA - Ucraina 12
UZ - Uzbekistan 12
IL - Israele 11
AT - Austria 10
CL - Cile 10
JO - Giordania 9
IR - Iran 8
LT - Lituania 8
VE - Venezuela 8
CH - Svizzera 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
EG - Egitto 6
MA - Marocco 6
AL - Albania 5
AM - Armenia 5
DZ - Algeria 5
KR - Corea 5
LB - Libano 5
NP - Nepal 5
PY - Paraguay 5
BG - Bulgaria 4
KE - Kenya 4
KG - Kirghizistan 4
MY - Malesia 4
PE - Perù 4
PT - Portogallo 4
UY - Uruguay 4
AZ - Azerbaigian 3
BY - Bielorussia 3
DK - Danimarca 3
HR - Croazia 3
KZ - Kazakistan 3
NO - Norvegia 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
SN - Senegal 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
DM - Dominica 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
NI - Nicaragua 2
QA - Qatar 2
UG - Uganda 2
BB - Barbados 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
GY - Guiana 1
IM - Isola di Man 1
IS - Islanda 1
Totale 10.602
Città #
Singapore 886
Chandler 665
Ashburn 530
Dallas 498
San Jose 417
The Dalles 327
Shanghai 256
Helsinki 224
Boardman 188
Wilmington 175
New York 158
Dublin 156
Beijing 117
Ho Chi Minh City 102
Los Angeles 83
Hanoi 81
Hong Kong 80
San Mateo 77
Paris 60
São Paulo 49
Amsterdam 46
Ann Arbor 46
Milan 45
Sassari 45
Benin City 41
London 38
Lawrence 35
Princeton 35
Assago 32
Leawood 31
Santa Clara 31
Council Bluffs 30
Pune 29
Falkenstein 28
Naples 27
Warsaw 25
Chennai 23
Phoenix 21
Woodbridge 21
Columbus 19
Da Nang 18
Brno 17
Munich 17
Orem 17
Seattle 17
Frankfurt am Main 16
Belo Horizonte 15
Boston 15
Brussels 15
Haiphong 15
Fairfield 13
Mexico City 13
Montreal 13
San Francisco 13
Stockholm 13
Curitiba 12
Rio de Janeiro 12
Tokyo 12
Brooklyn 11
Johannesburg 11
Tashkent 11
Brasília 10
Buenos Aires 9
Dhaka 9
Moscow 9
Porto Alegre 9
Skopje 9
Toronto 9
Houston 8
Quito 8
Amman 7
Bogotá 7
Goiânia 7
Guayaquil 7
Istanbul 7
Rome 7
Aurora 6
Baghdad 6
Jeddah 6
Kocaeli 6
Manchester 6
San Diego 6
Bitola 5
Biên Hòa 5
Campo Grande 5
Charlotte 5
Hangzhou 5
Jakarta 5
Jundiaí 5
Manaus 5
Miami 5
Mumbai 5
New Delhi 5
Poplar 5
Redwood City 5
Salvador 5
Secaucus 5
Vĩnh Long 5
West Jordan 5
Yerevan 5
Totale 6.321
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 686
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 203
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 137
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 128
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 126
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 120
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 115
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 109
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 106
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 106
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 105
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 102
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 101
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 101
5 reasons to encourage anti-SARS-CoV-2 vaccination in patients with rheumatic diseases 99
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 98
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 95
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 95
Liver involvement in subjects with rheumatic disease 94
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 91
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 90
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis 86
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study' 85
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 85
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 84
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 83
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 82
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 82
Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis 77
Analysis of interstitial lung involvement in a cohort of 100 patients with systemic sclerosis. Prevalence of alveolitis detected by bronchoalveolar lavage and HRCT 76
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 76
Liver abnormalities in connective tissue diseases 76
T-Cell response to carbamylated and citrullinated collagen epitopes in patients with rheumatoid arthritis carrying DRβ1*04 76
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. 76
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
Autoantibodies and organ involvement in systemic sclerosis 75
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 75
The role of Wnt pathway in the pathogenesis of OA and its potential therapeutic implications in the field of regenerative medicine 75
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 74
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 74
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 73
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 72
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 71
Artriti infettive 70
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids 69
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial 68
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 68
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 68
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 67
Type III interferons disrupt the lung epithelial barrier upon viral recognition 66
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 66
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 64
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 64
Viral Respiratory Pathogens and Lung Injury 64
The elegance of a macrophage 64
Gastrointestinal symptoms and nutritional profile during pregnancy 62
Add-on rituximab for primary heart involvement associated with systemic sclerosis: A step forward in the tailored treatment of myocarditis? 62
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 61
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: A report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group 61
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients 61
Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report 61
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 61
How advances in personalized medicine will change rheumatology 60
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 60
La sclerodermia 59
The therapeutic potential of epigenetics in autoimmune diseases 59
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency 58
BAFF and rheumatic autoimmune disorders: implications for disease management and therapy 58
Tumori ossei 58
The autoinflammatory side of systemic sclerosis 58
Digital ulcers predict a worse disease course in patients with systemic sclerosis 58
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 57
The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies 57
DRESS syndrome in response to Denosumab: First documented case report 57
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 56
Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis 56
Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate 56
Cancer in connective tissue disease 55
Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology 54
Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis 54
The genetic bases of asthma 53
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 53
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 53
Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis 53
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know 52
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 52
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum 51
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 51
The geoepidemiology of autoimmune liver disease 51
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature 51
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals 51
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis 50
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database 50
Septic sacroiliitis: an uncommon septic arthritis 50
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 50
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 49
IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy 49
Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing 48
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 47
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 47
Totale 7.884
Categoria #
all - tutte 61.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 39 2 58
2021/2022191 12 2 3 42 1 0 9 29 10 17 42 24
2022/20231.628 102 102 151 222 118 150 5 193 289 142 129 25
2023/20241.279 105 102 271 106 35 175 82 33 21 42 80 227
2024/20252.529 47 19 621 42 58 251 159 137 321 448 232 194
2025/20264.737 777 280 612 470 223 252 1.385 261 281 196 0 0
Totale 10.727